Boutique M&A niche Target mid-market biotech firms seeking discreet, specialized dealmaking support; position Double Helix M&A as a confidential, experienced partner for sellers and buyers looking to expand outreach and connect opportunities.

Strong value proposition Leverage the firm’s depth of experience, negotiation expertise, industry knowledge, creativity, and professionalism to differentiate from larger banks; offer tailored deal strategizing and confidential processes as a selling point to potential clients.

Revenue growth opportunities With sub $1M revenue, there is a prime opportunity to upsell advisory services such as deal sourcing, valuation, and cross-border M&A support to niche biotech startups and boutique spin-outs seeking strategic exits.

Competitive positioning Position against larger firms by emphasizing agility, confidentiality, and bespoke deal structuring; highlight success potential in targeted biotech subsectors to attract clients who value speed and discretion.

Targeted outreach channels Focus on relationships with emerging biotech labs, research institutions, and early-stage biotech funds; leverage existing network to generate inbound interest while offering a clear value proposition for sellers and buyers in their pipeline.